Moleac wins Singapore Entrepreneurial Company of the Year Award
Award recipients include:
BEST
PRACTICES
AWARD
PRACTICES
AWARD
Asia Pacific
Excellence inHealthcare Awards
Singapore
Entrepreneurial Company of the Year
Excellence inHealthcare Awards
Singapore
Entrepreneurial Company of the Year
10 SINGAPORE NEWS
The Business Times, Wednesday, April 22, 2009
Singapore Round Up
S'pore firm recognised for stroke drug
MOLEAC has been named Singapore Entrepreneurial Company of the Year in the Frost & Sullivan Asia Pacific Excellence in Healthcare Awards for the success of its stroke treatment drug NeuroAiD. The awards recognise players in various healthcare segments that have displayed best practices. Derived from traditional Chinese medicine, NeuroAiD helps people recover functional skills after a stroke.
S'pore firm recognised for stroke drug
MOLEAC has been named Singapore Entrepreneurial Company of the Year in the Frost & Sullivan Asia Pacific Excellence in Healthcare Awards for the success of its stroke treatment drug NeuroAiD. The awards recognise players in various healthcare segments that have displayed best practices. Derived from traditional Chinese medicine, NeuroAiD helps people recover functional skills after a stroke.
Mr. David Picard, CEO of Moleac Singapore, receiving the Frost & Sullivan Entrepreneurial Company of the Year Award from Mr. KC Yeoh, Execute Director Biomedical Sciences of the Economic Development Board of Singapore during the ceremony held on Wednesday April 22/2009 at the Intercontinental Hotel Singapore.
